A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects
NCT06973681 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2025-05-15
Summary
To assess the effect of BGM0504 injection versus placebo on weight loss in overweight or obese subjects after 24 weeks of treatment.
Conditions
- Overweight or Obesity
Interventions
- DRUG
-
BGM0504
Administered SC
- DRUG
-
BGM0504
Administered SC
- DRUG
-
BGM0504
Administered SC
- DRUG
-
Administered SC
Sponsors & Collaborators
-
BrightGene Bio-Medical Technology Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-13
- Primary Completion
- 2024-09-13
- Completion
- 2024-09-13
- FDA Drug
- Yes
Countries
- China
Study Locations
More Related Trials
-
A Study of HS-20094 in Chinese Adults with Overweight or Obesity
NCT06839664 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of IBI362 9 mg in Chinese Adults With Obesity
NCT06164873 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Injection in Non-diabetic Overweight or Obese Adult Subjects
NCT06714955 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of BGM0504 in Overweight or Obese Participants
NCT06920056 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
NCT06118021 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects
NCT06728124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
NCT04904913 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of IBI362 in Participants With Obesity or Overweight
NCT05607680 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of GZR18 Injection in Chinese Obese/Overweight Patients
NCT06256536 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of ZT006 in Overweight and Obese Participants
NCT07230132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
NCT05548231 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes
NCT04855292 ·Status: COMPLETED ·Phase: PHASE1
-
To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese
NCT06396429 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus
NCT07192263 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Phase I Study of GZR18 Injection in Obese/Overweight Subjects
NCT06548945 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects
NCT06953063 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects
NCT06350812 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects
NCT06974487 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of GZR18 Injection in Obese/Overweight Patients
NCT06256562 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults
NCT04116632 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects.
NCT06147544 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of TG103 Injection in Non-diabetic Overweight or Obesity
NCT05997576 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of ZT002 Injection in Participants With Overweight or Obesity
NCT06371326 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients
NCT06732960 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities
NCT06277934 ·Status: COMPLETED ·Phase: PHASE2